Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: South Korea Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20111
20132
20141
20151
20162
20191
20202
20211
20233
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Unknown status3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
AbbVie2
Alnylam Pharmaceuticals1
Aptamer Sciences, Inc.1
Blueprint Medicines Corporation1
Boryung Pharmaceutical Co., Ltd1
Coherus Oncology, Inc.1
Eli Lilly and Company1
Etnova Therapeutics Corp.1
Eutilex1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular25
Liver Neoplasms8
Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Biliary Tract Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Liver Diseases2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.